Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
boston blog main
clinical trials
national blog main
boston
boston top stories
san francisco blog main
acute migrane
ally bridge group
bain capital
bausch health
big data analytics
bioinnovation capital
biolabs
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
breast cancer
cancer
cancer drugs
casdin capital
chemotherapy
daraprim
deciphera pharmaceuticals
desmoid tumor
diabetic nephropathy
dihydroergotamine
dihydroergotamine mesylate
drug pricing
drugs
eli lilly
endometral cancer
epipen
epipens
europe blog main
european society for medical oncology
eventide asset management
exome
What
biotech
4
×
drug
4
×
ipo
companies
lead
leading
medicines
new
activity
analysis
bio
black
bring
cancer
clinic
company
days
develop
diamond
diseases
dog
driving
eluded
employing
firm
genetic
goldfinch
good
hasn’t
healthcare
history
hopes
improved
industry
innovation
innovations
investment
ipos
kidney
later
Language
unset
4
×
Current search:
drug
×
unset
×
biotech
×
biotech
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
